The synthesis and oral bioavallability of two potential prodrugs of Ganciclovir (1) based on the "trimethyl lock" is described. The mono-3-(2'-Acetoxy-4'6'-dimethylphenyl)-3,3-dimethylpropanoic ester (2) showed a four-fold increase in oral bioavallability over the parent drug in rats.